yes
they would have to go backwards in Q3 and Q4
if Q2 is $204m and
Q1 is $186m
to not break above the $800m top end of guidance
that's not really possible ?
RLS going great guns .. what a great buy ?
they will be above the US$800 without :
1. any sales of Gozellix in 2025 and ( i assume full reimbursement in Q4)
2. Illuccix in ex USA jurisdictions ( dunno ... its going to sell ... we just dont know how much .. a little a lot ... heaps = will add to the $800 guidance)
Ann: Telix Reports US$204M Q2 Revenue, Up 63% YOY, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$20.15 |
Change
-0.900(4.28%) |
Mkt cap ! $6.818B | |||
| Open | High | Low | Value | Volume |
| $20.90 | $21.05 | $19.98 | $83.37M | 4.086M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 366 | $20.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.17 | 250 | 1 |
View Market Depth
| Last trade - 16.11pm 01/08/2025 (20 minute delay) ? |
| TLX (ASX) Chart |